ADRENAL GLAND PHEOCHROMOCYTOMA
Clinical trials for ADRENAL GLAND PHEOCHROMOCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ADRENAL GLAND PHEOCHROMOCYTOMA trials appear
Sign up with your email to follow new studies for ADRENAL GLAND PHEOCHROMOCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…
Matched conditions: ADRENAL GLAND PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 06:51 UTC
-
New drug duo targets Hard-to-Treat rare cancers
Disease control OngoingThis study is testing whether a combination of two oral drugs, talazoparib and temozolomide, can shrink advanced rare cancers that have spread and for which standard treatments have stopped working. The trial aims to see if this drug pair can stop tumor growth by damaging cancer …
Matched conditions: ADRENAL GLAND PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC